Atlas Trials

Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery

Clinical trial NCT00468429 · UNKNOWN

Trial details

NCT number
NCT00468429
Sponsor
Grewal Eye Institute
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Glaucoma
Start date
2007-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.